Browsing Category

65902 posts
Akeso Announced the First Patient Dosed in Phase III Trial of Cadonilimab(PD-1/CTLA-4) Combined with Chemotherapy versus Tislelizumab Combined with Chemotherapy in First-line Treatment of PD-L1 negative NSCLC

Akeso Announced the First Patient Dosed in Phase III Trial of Cadonilimab(PD-1/CTLA-4) Combined with Chemotherapy versus Tislelizumab Combined with Chemotherapy in First-line Treatment of PD-L1 negative NSCLC

HONG KONG, March 6, 2024 /PRNewswire/ — Akeso Inc. ("Akeso", 9926. HK) announced…
MAG GROUP HOLDING RECORDS OVER AED 12.6 BILLION SALES IN 2023

MAG GROUP HOLDING RECORDS OVER AED 12.6 BILLION SALES IN 2023

DUBAI, UAE, March 6, 2024 /PRNewswire/ — MAG Group Holding, the multinational…
Yatsen Announces Fourth Quarter and Full Year 2023 Financial Results

Yatsen Announces Fourth Quarter and Full Year 2023 Financial Results

Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on…
iQIYI Expands Offline VR Immersive Theater into the Historic City of Xi'an, Merging IP, Technology, and Cultural Tourism

iQIYI Expands Offline VR Immersive Theater into the Historic City of Xi'an, Merging IP, Technology, and Cultural Tourism

BEIJING, March 6, 2024 /PRNewswire/ — iQIYI, an innovative market-leading online entertainment…
JA Solar Signs Cooperation Declaration with CMA CGM

JA Solar Signs Cooperation Declaration with CMA CGM

BEIJING, March 6, 2024 /PRNewswire/ — On 28 February, JA Solar, a…
Digital Twins: A New Model for Urban Governance

Digital Twins: A New Model for Urban Governance

BEIJING, March 6, 2024 /PRNewswire/ – By China Report ASEAN A vivid…
Commercial Aerospace: The Next Launchpad for the Chinese Economy

Commercial Aerospace: The Next Launchpad for the Chinese Economy

BEIJING, March 6, 2024 /PRNewswire/ — By China Report ASEAN On December 29,…
YPO Names Gene Gebolys the 2024 Global Impact Award Recipient

YPO Names Gene Gebolys the 2024 Global Impact Award Recipient

NEW YORK, March 6, 2024 /PRNewswire/ — Today, YPO, the global leadership…